SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?


To: Peter Dierks who wrote (2205)10/16/2007 11:29:09 AM
From: TimF  Read Replies (1) | Respond to of 42652
 
The Saga Of Socialized Medicine (Cont'd)

By INVESTOR'S BUSINESS DAILY | Posted Monday, October 15, 2007 4:30 PM PT

Health Care: On Monday we reported on the filthy conditions in some British hospitals. Now we hear that some Brits pull their own teeth because they can't find a dentist in that vaunted government system of theirs.

A recent poll found that 35% of Britons say they can't find a National Health Services dentist near their home, 22% claim they don't know how to find a dentist, and 13% are on a waiting list. For 6% of the respondents, self-treatment, including garden-shed extractions, is the alternative.

Meanwhile, in the private U.S. health care system — the one that many want to trade in for the British model — the decline in cancer death rates has accelerated to nearly twice the previous rate.

The "Annual Report to the Nation on the Status of Cancer" released Monday indicates that cancer deaths fell an average of 2.1% a year from 2002 to 2004. From 1993 to 2002, they fell at an annual rate of 1.1%.

Much of the progress was due to the improved treatment of colorectal cancer, the No. 2 killer behind lung cancer. A decade ago, colorectal cancer drug therapy was limited to one effective medicine. Now there are seven on the market that can be combined in cocktails that restrain tumor growth and increase lifespans.

We cheer Dr. John R. Seffrin, chief executive of the American Cancer Society, when he says, "We are truly turning the tide in the cancer battle." But we believe he's way off the mark when he also asserts that the gains "could be even greater if everyone in the U.S. had access to essential health care, including primary care and prevention services."

Were the U.S. to collapse into a British- or Canadian-style socialist system, private-sector incentives to invest in the development of new drugs so instrumental in cutting death rates would be diluted.

For each new drug brought to market, pharmaceutical companies spend $800 million to $1 billion in research and development costs. If they aren't able to recover those costs and make a profit beyond that, they have no reason to innovate.

You don't have to be a member of the vast right-wing conspiracy to realize that America, where health care has yet to be fully seized by the state, provides a rich market for drug makers, and that nations with socialist systems that are funded by taxpayers are poor markets for the industry and thus hurdles to innovation.

The incentive to invest should never be undervalued. A few years ago, the Commerce Department reported that drug price controls in just the largest industrialized nations reduce drug R&D by between $5 billion and $6 billion a year around the world. That means fewer new drugs are produced, which means shorter and more miserable lives for those suffering with disease.

In a sense, Americans subsidize prescription drugs for the rest of the world. Because government-run systems place artificial price ceilings on their products, pharmaceutical companies have to make big money in the U.S. to make up for low profit margins in other nations. Using the power of government to make drug prices more "affordable" in the U.S., a longtime goal of the left, would have devastating effects not only here but across the globe.

"The U.S. is paying the lion's share of R&D," former IBD columnist Merrill Matthews wrote in 2004's "Riding On The Coattails Of U.S. Patients" for the Institute for Policy Innovation.

"That has to change," Matthews wrote. "If other countries want to reinvigorate their R&D sectors, which have been pulling up stakes and moving to the friendlier U.S. economic climate, they have to be willing to relax their price controls and let the prices rise.

"The result is they will be paying a greater share of the R&D, but they will likely also find that innovation-driven companies are willing to settle — or resettle — in those countries, pumping up the economies and creating good jobs."

Canada and the U.K. need the system we have, not vice versa. But they've grown accustomed to their current setups and naively think care is free. Getting them to change would be like pulling teeth.

ibdeditorials.com



To: Peter Dierks who wrote (2205)10/29/2007 1:54:20 AM
From: Peter Dierks  Respond to of 42652
 
Unlearned Lessons: HillaryCare II
By Jonah Goldberg
Friday, October 5, 2007

The year was 1993. Israel and the PLO signed an agreement on the White House lawn that, we were told, would lead to a lasting peace. Islamic terrorists tried to blow up the World Trade Center. When they were finally convicted, the federal government claimed an important message had been sent to terrorists everywhere: Stay away from the USA. The president also ordered the bombing of Iraq that year, to send another important signal that misbehavior in Mesopotamia would not be tolerated. On the home front, the president put his wife in charge of overhauling the health care system.

Well, considering this boffo record of success, it seems only fitting that Sen. Hillary Clinton would head back to the health care well.

To paraphrase William Faulkner: History isn’t dead; it’s not even past. This time around, though, Clinton claims history isn’t repeating itself with her new health care plan. Far from it: She has learned from her mistakes, and she’s “got the scars to prove it.” This time Clinton — as well as several of her primary opponents — proposes “flexible” reforms that would preserve consumer “choice.” This is supposedly the grand lesson Clinton learned from her many political scars: People don’t want government-run health care.

But she might want to study her mistakes a bit more closely because her alternative is to provide government-run health insurance, which ultimately is the same thing. Clinton’s plan would yank insurance regulation from the states and impose a series of federal mandates on employers, individuals and insurance companies. Insurers would have to cover anybody who knocks on their door. Individuals would be required by law to have health coverage, just as drivers are required to have auto insurance. Clinton claims she would make her system affordable by regulating both premiums and benefits, offering tax breaks and subsidies to the poor and middle class, and by offering a fallback government-run plan that would compete with the private plans. The Democrats insist this doesn’t amount to government-run health care, but it would be more honest to say that it doesn’t amount to government-run health care right away.

First of all, forcing people to buy health insurance whether they want to or not is somewhat at odds with the idea that her plan champions “choice.” More important, forcing companies to cover everybody means the risk pool for insurance companies gets riskier and, hence, more expensive. Costs would rise, and so young healthy people would rationally opt for as little coverage as possible, because presumably bare-bones coverage would be much cheaper.

Boosters of these plans claim that the healthy “competition” between the government and the private sector would drive prices lower. But how, exactly, can private companies compete against a government plan that cares nothing about making a profit? Because there’s no free lunch, the government costs would have to be made up elsewhere — through higher taxes and mandated higher premiums for people who can afford their own health insurance.

In states where such plans have been tried, such as Kentucky and Washington, the response by the private insurance companies has been a Monty Pythonesque “Run away! Run away!”, leaving behind pretty much only single-payer systems and angry customers, patients and voters. This is the model Clinton et al. want to impose at the national level. Indeed, John Edwards boasts that “over time,” his plan “may evolve toward a single-payer approach.” That single payer is you, Mr. Taxpayer.

Democrats may have invented new bells and whistles, but their thinking hasn’t changed much since 1993. Back then, they believed there was a “health care crisis,” and the solution required big-footed feds to stomp all over the existing system. What they didn’t take into account is the fact that millions of Americans were satisfied with their health care. The Democrats’ response now is to say, “but you can keep your doctor.” That’s nice, but it still misses the point.

Today, among the insured — a group far larger and more likely to vote than the uninsured — people actually like the status quo. A recent Kaiser Foundation poll on health care found that 88 percent of those with insurance thought their coverage was good or excellent while 93 percent were happy with their quality of care. And 64 percent said they were happy with their health care costs. Meanwhile, a recent Gallup Poll found that trust in the federal government is the lowest ever recorded. This is not quite the kindling for revolutionary change many liberals think is out there.

The GOP understands this. As Yuval Levin of the Ethics and Public Policy Center recently noted in the Weekly Standard, the Republican candidates as well as the White House have collectively pushed a number of reforms that would expand consumer choice without necessarily expanding government. By changing the way health care is taxed and using government purchasing power more efficiently, they aim toward decoupling the New Deal-era system of using big business to provide health care. Some propose following what Mitt Romney did when he was governor in Massachusetts and offering subsidies to those who can’t afford insurance.

None of these plans is perfect, but all recognize that the federal government cannot simply impose a solution without creating the sorts of problems that plague all other single-payer systems — rationing, long lines and ever-higher taxes. Moreover, these approaches are probably more appealing to the vast swath of voters who don’t live inside the Democratic bubble.

And that’s the irony of Hillary Clinton’s claim to have learned so much from her last failure, which cost Democrats the Congress and largely hobbled the liberal aspirations of the her husband’s presidency. If the most famous champion of nationalized health care in U.S. history wins the nomination and voters start paying attention, they might easily conclude that Hillary and her party haven’t learned anything at all.

Jonah Goldberg is editor-at-large of National Review Online.

townhall.com